Copyright
©The Author(s) 2025.
World J Clin Oncol. Mar 24, 2025; 16(3): 94091
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.94091
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.94091
Figure 2 Expression of transmembrane channel-like 5 in hepatocellular carcinoma tissue and cell lines.
A: Immunohistochemistry analysis of transmembrane channel-like 5 (TMC5) expression in Hepatocellular carcinoma tumor and paracancerous tissues (n = 10). Original magnification, 20 ×, scale bar = 100 μm; B: RT-qPCR was performed to detect the expression of TMC5 in LO2, MHCC-97H and MHCC97-LM3 (n = 3). HCC: Hepatocellular carcinoma; IHC: Immunohistochemistry; TMC5: Transmembrane channel-like 5. aP < 0.01.
- Citation: Li J, Wang ZY, Jin Y, Xu J, Ya YJ, Wan TQ, Li X, Wang X. Transmembrane channel-like 5 drives hepatocellular carcinoma progression by regulating epithelial-mesenchymal transition. World J Clin Oncol 2025; 16(3): 94091
- URL: https://www.wjgnet.com/2218-4333/full/v16/i3/94091.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i3.94091